Immuron

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immuron and other ETFs, options, and stocks.

About IMRN

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. Its proprietary technology is based on polyclonal immunoglobulins derived from engineered hyper-immune bovine colostrum.

CEO

Steven Lydeamore

CEOSteven Lydeamore

Employees

—

Employees—

Headquarters

Carlton, Victoria (VIC)

HeadquartersCarlton, Victoria (VIC)

Founded

1994

Founded1994

Employees

—

Employees—

IMRN Key Statistics

Market cap

16.49M

Market cap16.49M

Price-Earnings ratio

-5.75

Price-Earnings ratio-5.75

Dividend yield

—

Dividend yield—

Average volume

27.93K

Average volume27.93K

High today

$2.65

High today$2.65

Low today

$2.40

Low today$2.40

Open price

$2.40

Open price$2.40

Volume

15.37K

Volume15.37K

52 Week high

$5.96

52 Week high$5.96

52 Week low

$1.48

52 Week low$1.48

IMRN News

TipRanks 5h

Immuron CEO to Discuss Travelan® and Future Plans - TipRanks.com - TipRanks

Immuron Limited (AU:IMC) has released an update. Immuron Limited, an Australian biopharmaceutical company, announces that CEO Steven Lydeamore will present at...